Use of epothelone D in treating Tauassociated diseases including Alzheimer's disease

Details for Australian Patent Application No. 2009240538 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Albright, Charles F.; Lee, Francis Y.; Barten, Donna Marie

Agent A J Park

Pub. Number AU-A-2009240538

PCT Pub. Number WO2009/132253

Priority 61/047,729 24.04.08 US

Filing date 24 April 2009

Wipo publication date 29 October 2009

International Classifications

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/00 (2006.01) Drugs for disorders of the senses

Event Publications

4 November 2010 PCT application entered the National Phase

  PCT publication WO2009/132253 Priority application(s): WO2009/132253

23 December 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read Use of Epothilone D in treating Tau-associated diseases including Alzheimer's disease

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009240548-Input protection circuit

2009240528-In kind participating preferred security